Literature DB >> 24500652

Submandibular gland needle biopsy for the diagnosis of Parkinson disease.

Charles H Adler1, Brittany N Dugger, Michael L Hinni, David G Lott, Erika Driver-Dunckley, Jose Hidalgo, Jonette Henry-Watson, Geidy Serrano, Lucia I Sue, Thomas Nagel, Amy Duffy, Holly A Shill, Haruhiko Akiyama, Douglas G Walker, Thomas G Beach.   

Abstract

OBJECTIVE: This study investigates salivary gland biopsies in living patients with Parkinson disease (PD).
METHODS: Patients with PD for ≥5 years underwent outpatient transcutaneous needle core biopsies (18-gauge or 16-gauge) of 1 submandibular gland. Minor salivary glands were removed via a small incision in the lower lip. Tissue was fixed in formalin and serial 6-µm paraffin sections were immunohistochemically stained for phosphorylated α-synuclein and reviewed for evidence of Lewy type α-synucleinopathy (LTS).
RESULTS: Fifteen patients with PD were biopsied: 9 female/6 male, mean age 68.7 years, mean PD duration 11.8 years. Twelve of the needle core biopsies had microscopically evident submandibular gland tissue to assess and 9/12 (75%) had LTS. Only 1/15 (6.7%) minor salivary gland biopsies were positive for LTS. Five patients had an adverse event; all were minor and transient.
CONCLUSIONS: This study demonstrates the feasibility of performing needle core biopsies of the submandibular gland in living patients with PD to assess LTS. Although this was a small study, this tissue biopsy method may be important for tissue confirmation of PD in patients being considered for invasive procedures and in research studies of other PD biomarkers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500652      PMCID: PMC3959757          DOI: 10.1212/WNL.0000000000000204

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

Authors:  Heiko Braak; Rob A I de Vos; Jürgen Bohl; Kelly Del Tredici
Journal:  Neurosci Lett       Date:  2005-12-05       Impact factor: 3.046

Review 2.  Neuropathology of Parkinson's disease and related syndromes.

Authors:  W R Gibb
Journal:  Neurol Clin       Date:  1992-05       Impact factor: 3.806

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Authors:  Hideo Fujiwara; Masato Hasegawa; Naoshi Dohmae; Akiko Kawashima; Eliezer Masliah; Matthew S Goldberg; Jie Shen; Koji Takio; Takeshi Iwatsubo
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

5.  Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

Authors:  A J Hughes; S E Daniel; A J Lees
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

Review 6.  Lewy bodies in the enteric nervous system in Parkinson's disease.

Authors:  K Wakabayashi; H Takahashi; S Takeda; E Ohama; F Ikuta
Journal:  Arch Histol Cytol       Date:  1989

Review 7.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

8.  Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.

Authors:  K Wakabayashi; H Takahashi; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

9.  Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.

Authors:  Annemarie M M Vlaar; Tjerk de Nijs; Alfons G H Kessels; Fred W Vreeling; Ania Winogrodzka; Werner H Mess; Selma C Tromp; Marinus J P G van Kroonenburgh; Wim E J Weber
Journal:  Eur Neurol       Date:  2008-02-08       Impact factor: 1.710

10.  Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

Authors:  A Minguez-Castellanos; C E Chamorro; F Escamilla-Sevilla; A Ortega-Moreno; A C Rebollo; M Gomez-Rio; A Concha; D G Munoz
Journal:  Neurology       Date:  2007-06-05       Impact factor: 9.910

View more
  41 in total

Review 1.  Advances in Biomarker Research in Parkinson's Disease.

Authors:  Shyamal H Mehta; Charles H Adler
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

Review 3.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  LRRK2 in Parkinson disease: challenges of clinical trials.

Authors:  Eduardo Tolosa; Miquel Vila; Christine Klein; Olivier Rascol
Journal:  Nat Rev Neurol       Date:  2020-01-24       Impact factor: 42.937

5.  Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Authors:  Liancai Mu; Jingming Chen; Stanislaw Sobotka; Themba Nyirenda; Brian Benson; Fiona Gupta; Ira Sanders; Charles H Adler; John N Caviness; Holly A Shill; Marwan Sabbagh; Johan E Samanta; Lucia I Sue; Thomas G Beach
Journal:  Dysphagia       Date:  2015-06-04       Impact factor: 3.438

Review 6.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

7.  Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.

Authors:  Naomi P Visanji; Connie Marras; Drew S Kern; Amaal Al Dakheel; Andrew Gao; Louis W C Liu; Anthony E Lang; Lili-Naz Hazrati
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

Review 8.  How strong is the evidence that Parkinson's disease is a prion disorder?

Authors:  Patrik Brundin; Jiyan Ma; Jeffrey H Kordower
Journal:  Curr Opin Neurol       Date:  2016-08       Impact factor: 5.710

9.  The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.

Authors:  Brittany N Dugger; Charisse M Whiteside; Chera L Maarouf; Douglas G Walker; Thomas G Beach; Lucia I Sue; Angelica Garcia; Travis Dunckley; Bessie Meechoovet; Eric M Reiman; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 10.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

Authors:  Heiko Braak; Kelly Del Tredici
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-11-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.